172 related articles for article (PubMed ID: 14668715)
1. Results of initial operation for hyperparathyroidism in patients with multiple endocrine neoplasia type 1.
Elaraj DM; Skarulis MC; Libutti SK; Norton JA; Bartlett DL; Pingpank JF; Gibril F; Weinstein LS; Jensen RT; Marx SJ; Alexander HR
Surgery; 2003 Dec; 134(6):858-64; discussion 864-5. PubMed ID: 14668715
[TBL] [Abstract][Full Text] [Related]
2. Primary hyperparathyroidism in multiple endocrine neoplasia type 1: individualized management with low recurrence rates.
Lee CH; Tseng LM; Chen JY; Hsiao HY; Yang AH
Ann Surg Oncol; 2006 Jan; 13(1):103-9. PubMed ID: 16378158
[TBL] [Abstract][Full Text] [Related]
3. Optimal extent of initial parathyroid resection in patients with multiple endocrine neoplasia syndrome type 1: A meta-analysis.
Nastos C; Papaconstantinou D; Kofopoulos-Lymperis E; Peppa M; Pikoulis A; Lykoudis P; Palazzo F; Patapis P; Pikoulis E
Surgery; 2021 Feb; 169(2):302-310. PubMed ID: 33008613
[TBL] [Abstract][Full Text] [Related]
4. Unilateral Clearance for Primary Hyperparathyroidism in Selected Patients with Multiple Endocrine Neoplasia Type 1.
Kluijfhout WP; Beninato T; Drake FT; Vriens MR; Gosnell J; Shen WT; Suh I; Liu C; Duh QY
World J Surg; 2016 Dec; 40(12):2964-2969. PubMed ID: 27402205
[TBL] [Abstract][Full Text] [Related]
5. Subtotal parathyroidectomy as an adequate treatment for primary hyperparathyroidism in multiple endocrine neoplasia type 1.
Hubbard JG; Sebag F; Maweja S; Henry JF
Arch Surg; 2006 Mar; 141(3):235-9. PubMed ID: 16549687
[TBL] [Abstract][Full Text] [Related]
6. Long-term results of less than total parathyroidectomy for hyperparathyroidism in multiple endocrine neoplasia type 1.
Arnalsteen LC; Alesina PF; Quiereux JL; Farrel SG; Patton FN; Carnaille BM; Cardot-Bauters CM; Wemeau JL; Proye CA
Surgery; 2002 Dec; 132(6):1119-24; discussion 1124-5. PubMed ID: 12490864
[TBL] [Abstract][Full Text] [Related]
7. Recurrent hyperparathyroidism and forearm parathyromatosis after total parathyroidectomy.
Melck AL; Carty SE; Seethala RR; Armstrong MJ; Stang MT; Ogilvie JB; Yip L
Surgery; 2010 Oct; 148(4):867-73; discussion 873-5. PubMed ID: 20800255
[TBL] [Abstract][Full Text] [Related]
8. Is total parathyroidectomy the treatment of choice for hyperparathyroidism in multiple endocrine neoplasia type 1?
Tonelli F; Marcucci T; Fratini G; Tommasi MS; Falchetti A; Brandi ML
Ann Surg; 2007 Dec; 246(6):1075-82. PubMed ID: 18043113
[TBL] [Abstract][Full Text] [Related]
9. The outcome of subtotal parathyroidectomy for the treatment of hyperparathyroidism in multiple endocrine neoplasia type 1.
Burgess JR; David R; Parameswaran V; Greenaway TM; Shepherd JJ
Arch Surg; 1998 Feb; 133(2):126-9. PubMed ID: 9484721
[TBL] [Abstract][Full Text] [Related]
10. Minimally invasive parathyroidectomy provides a conservative surgical option for multiple endocrine neoplasia type 1-primary hyperparathyroidism.
Versnick M; Popadich A; Sidhu S; Sywak M; Robinson B; Delbridge L
Surgery; 2013 Jul; 154(1):101-5. PubMed ID: 23809488
[TBL] [Abstract][Full Text] [Related]
11. A randomized, prospective trial of operative treatments for hyperparathyroidism in patients with multiple endocrine neoplasia type 1.
Lairmore TC; Govednik CM; Quinn CE; Sigmond BR; Lee CY; Jupiter DC
Surgery; 2014 Dec; 156(6):1326-34; discussion 1334-5. PubMed ID: 25262224
[TBL] [Abstract][Full Text] [Related]
12. Causes and treatment of recurrent hyperparathyroidism after subtotal parathyroidectomy in the presence of multiple endocrine neoplasia 1.
Salmeron MD; Gonzalez JM; Sancho Insenser J; Goday A; Perez NM; Zambudio AR; Paricio PP; Serra AS
World J Surg; 2010 Jun; 34(6):1325-31. PubMed ID: 20431882
[TBL] [Abstract][Full Text] [Related]
13. Benefit of diverse surgical approach on short-term outcomes of MEN1-related hyperparathyroidism.
Choi HR; Choi SH; Choi SM; Kim JK; Lee CR; Kang SW; Lee J; Jeong JJ; Nam KH; Chung WY; Lee S; Hong N; Rhee Y
Sci Rep; 2020 Jun; 10(1):10634. PubMed ID: 32606444
[TBL] [Abstract][Full Text] [Related]
14. Prospective study of surgery for primary hyperparathyroidism (HPT) in multiple endocrine neoplasia-type 1 and Zollinger-Ellison syndrome: long-term outcome of a more virulent form of HPT.
Norton JA; Venzon DJ; Berna MJ; Alexander HR; Fraker DL; Libutti SK; Marx SJ; Gibril F; Jensen RT
Ann Surg; 2008 Mar; 247(3):501-10. PubMed ID: 18376196
[TBL] [Abstract][Full Text] [Related]
15. Surgical management of hyperparathyroidism in patients with multiple endocrine neoplasia type 2A.
Herfarth KK; Bartsch D; Doherty GM; Wells SA; Lairmore TC
Surgery; 1996 Dec; 120(6):966-73; discussion 973-4. PubMed ID: 8957482
[TBL] [Abstract][Full Text] [Related]
16. Total parathyroidectomy in a large cohort of cases with hyperparathyroidism associated with multiple endocrine neoplasia type 1: experience from a single academic center.
Montenegro FL; Lourenço DM; Tavares MR; Arap SS; Nascimento CP; Massoni Neto LM; D'Alessandro A; Toledo RA; Coutinho FL; Brandão LG; de Britto e Silva Filho G; Cordeiro AC; Toledo SP
Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):131-9. PubMed ID: 22584718
[TBL] [Abstract][Full Text] [Related]
17. Short- and long-term outcome of total parathyroidectomy with immediate autografting versus subtotal parathyroidectomy in patients with end-stage renal disease.
Hargrove GM; Pasieka JL; Hanley DA; Murphy MB
Am J Nephrol; 1999; 19(5):559-64. PubMed ID: 10575184
[TBL] [Abstract][Full Text] [Related]
18. Limited Parathyroidectomy in Multiple Endocrine Neoplasia Type 1-Associated Primary Hyperparathyroidism: A Setup for Failure.
Nilubol N; Weinstein LS; Simonds WF; Jensen RT; Marx SJ; Kebebew E
Ann Surg Oncol; 2016 Feb; 23(2):416-23. PubMed ID: 26542588
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Surveillance of Treated Hyperparathyroidism for Multiple Endocrine Neoplasia Type 1: Recurrence or Hypoparathyroidism?
Fyrsten E; Norlén O; Hessman O; Stålberg P; Hellman P
World J Surg; 2016 Mar; 40(3):615-21. PubMed ID: 26541865
[TBL] [Abstract][Full Text] [Related]
20. Single gland excision for MEN1-associated primary hyperparathyroidism.
Manoharan J; Albers MB; Bollmann C; Maurer E; Mintziras I; Wächter S; Bartsch DK
Clin Endocrinol (Oxf); 2020 Jan; 92(1):63-70. PubMed ID: 31626728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
